BIONET Balance Sheet Health
Financial Health criteria checks 5/6
BIONET has a total shareholder equity of NT$2.2B and total debt of NT$65.0M, which brings its debt-to-equity ratio to 3%. Its total assets and total liabilities are NT$2.9B and NT$770.3M respectively. BIONET's EBIT is NT$52.6M making its interest coverage ratio -2.5. It has cash and short-term investments of NT$1.3B.
Key information
3.0%
Debt to equity ratio
NT$65.00m
Debt
| Interest coverage ratio | -2.5x |
| Cash | NT$1.35b |
| Equity | NT$2.15b |
| Total liabilities | NT$770.34m |
| Total assets | NT$2.92b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 1784's short term assets (NT$1.8B) exceed its short term liabilities (NT$418.9M).
Long Term Liabilities: 1784's short term assets (NT$1.8B) exceed its long term liabilities (NT$351.4M).
Debt to Equity History and Analysis
Debt Level: 1784 has more cash than its total debt.
Reducing Debt: 1784's debt to equity ratio has increased from 0% to 3% over the past 5 years.
Debt Coverage: 1784's debt is well covered by operating cash flow (255.1%).
Interest Coverage: 1784 earns more interest than it pays, so coverage of interest payments is not a concern.